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Abstract
Background: Melanin production in medullary carcinoma is extremely uncommon.
Case presentation: We report a rare variant of medullary carcinoma of thyroid with melanin
production in a 52-year-old woman who presented with swelling in the thyroid of 3 months
duration. This tumor recurred thrice in two years after surgery and patient died with metastasis.
Microscopic examination showed typical morphology of medullary carcinoma with numerous cells
loaded with melanin pigment as confirmed by bleached Fontana-Masson, negative iron and
immunohistochemical stains. Tumor cells were diffusely immunopositive for calcitonin, HMB-45,
chromogranin, synaptophysin, CEA but showed focal paranuclear dot positivity for cytokeratin. No
C-cell hyperplasia was seen in the adjacent thyroid gland. Nature of the pigment was further
confirmed on ultra structural examination.
Conclusion: Melanotic medullary carcinoma is an extremely uncommon entity. There is a need
to report more number of cases in the literature for exact categorization and prognostication of
this subtype of medullary carcinoma.
Background
Hazard et al segregated medullary carcinoma of thyroid
(MTC) as a distinct entity in 1959 [1]. Calcitonin produc-
tion by tumor cells is distinct and proves its origin from C-
cells [2]. Medullary carcinoma cells have a confirmed abil-
ity to have a multi directional differentiation. Tumor cells
are known to produce array of hormonal and non-hormo-
nal products including mucin, peptides and amines [2].
Melanin production in medullary carcinoma is extremely
uncommon and to the best of our knowledge only nine
such cases have been reported in the literature [3-11]
(Table 1). Melanocytic differentiation with melanin pro-
duction is very rare, thus needs to be documented in order
to know the exact behavior of this variant.
Case presentation
A 52-year-old female presented with swelling in the neck,
in the thyroid region, of 3 months duration. She com-
plained of difficulty in swallowing and pain in the swell-
ing for the last fifteen days. Clinically, she was euthyroid
and there was no past history of exposure to radiation.
Routine blood examination and serum chemistry revealed
no abnormalities. Serum T3, T4 and TSH levels were nor-
mal. Renal function and liver function tests were normal.
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There was no family history of thyroid disease. She was a
known hypertensive on treatment. On examination a 3 ×
2 cm lump was palpable in the lower part of neck, more
so on the right side. This swelling moved with deglutition.
No lymph nodes were palpable in the neck. No clinical
evidence of abnormal parathyroid activity, Cushing syn-
drome, subcutaneous nodules or mucosal neuromas was
present.
Computerized tomography (CT) scan neck showed a 3.5
× 2.5 cm hyper dense lesion in the right lobe of the thy-
roid without any associated lymphadenopathy. Fine nee-
dle aspiration cytology (FNAC) was suggestive of a poorly
differentiated carcinoma. On laryngoscopic examination,
bilateral vocal cords were mobile. Near total thyroidec-
tomy was done without lymph node dissection. Post-
operative period was uneventful. Unfortunately, serum
calcitonin level was not estimated preoperatively but post-
operative serum calcium and calcitonin levels were within
normal limits. Thyroid weighed 24 gm and thyroid cap-
sule was intact. Cut surface showed a single nodule meas-
uring 3.1 × 2.2 × 1.1 cm within the right lobe of thyroid.
Nodule was partially encapsulated but well demarcated
from adjacent normal appearing thyroid. Cut section of
nodule was soft homogeneously black in color with grey
white foci (Fig 1a). No satellite nodule was seen in the rest
of the thyroid. Lymph nodes were not found in the speci-
men.
Tissue was fixed in 10% neutral buffered formalin, rou-
tinely processed and paraffin embedded. Five micron
thick sections were cut for hematoxylin and eosin staining
and immunohistochemistry. Immunohistochemical
staining was done by streptavidin-biotin peroxidase com-
plex method and a panel of antibodies was used to char-
acterize the tumor. These include thyroglobulin (dil
1:50), thyroid transcription factor (TTF, dil 1:100), synap-
tophysin (dil 1:50), carcinoembryonic antigen(CEA, dil
1:100), melan A(dil 1: 100), epithelial membrane antigen
(EMA, dil 1:50), pancytokeratin (CK; dil 1:100), cytoker-
atin 19 (dil 1:100), S-100 protein (dil 1:100), vimentin
(dil 1:100), chromogranin (dil 1:50), calcitonin (dil
1:50), HMB 45 (dil:100), p53 (dil 1:50), bcl-2 (dil 1:50)
Gross photograph showing cut surface of right lobe of thy- roid demonstrating a well circumscribed black colored nod- ule Figure 1
Gross photograph showing cut surface of right lobe of thy-
roid demonstrating a well circumscribed black colored nod-
ule, (1a); photomicrograph shows encapsulated nodule 
compressing adjacent normal thyroid (1b, H&E, ×100); 
caught up normal thyroid follicles in the tumor (1c, H&E, 
×200); higher magnification demonstrating plasmacytoid 
appearance of tumor cells (1d, H&E, ×200); tumor cells con-
taining brownish black pigment and focal areas of spindling 
(1e, H&E, ×200); high magnification shows tumor cells laden 
with melanin (1f, H&E, ×400)
Table 1: Summary of published cases of melanotic medullary carcinoma thyroid
S. No. Author & Year Age 
& Sex
Duration of 
symptoms
Histology Pigmentation Follow up
1. Marcus JN 1982 [3] 53/M 15 days Classic Dendritic cells Dendritic cells No evidence of recurrence or 
metastasis 2.5 years after surgery
2. Posen JA 1984 [4] 38/F 5 years Classic -- Diffuse Not mentioned
3. Eng HL 1989 [5] 68/F 1 month Classic Dendritic cells Dendritic cells Not mentioned
4. Kimura N 1989 [6] 62/M 2 years Classic Glandular Both 
components
2 years metastasis
5. Beerman H 1990 [7] 48/F 15 days Classic Spindle cells Spindle cells 13 months died with metastasis
36/F 14 years Classic -- Diffuse 20 months
6. Romdhane KP 1995 [8] 51/M 10 years Paraganglioma 
like
Dendritic cells Dendritic cells No evidence of recurrence or 
metastasis 1 year after surgery
7. Ikeda T 1998 [9] 72/F 2 months Paraganglioma 
like
Sustentacular 
cells
Sustentacular 
cells
Not mentioned
8. Singh ZN 1999 [10] 55/F 4 months Typical -- Diffuse Presented with LN metastasis; No 
evidence of metastasis after 1 year
9. De Lume MA 2001 [11] 20/M 9 months Classic -- Diffuse Not mentioned
10. Present case 52/F 3 months Classic -- Diffuse 24 months, recurred thrice, 
metastasis to skull bones and diedDiagnostic Pathology 2008, 3:2 http://www.diagnosticpathology.org/content/3/1/2
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and MIB-1 (dil 1:50). All antibodies were obtained from
M/s Dako Patts, Denmark except p53 and TTF which were
procured from M/s Novocastra UK and M/s Neomarker,
USA respectively. High temperature antigen retrieval
using microwave was carried out by immersing the sec-
tions in 10 mM citrate buffer (pH 6.0) and heating inside
a 750 watt microwave oven in full power for 30 minutes
except for chromogranin, HMB-45, S-100 and EMA.
MIB-LI was calculated as percentage positive nuclei in the
highest labeled areas. For electron microscopy, the tissue
was fixed in 2.5% glutaraldehyde, post-fixed with 1%
osmic acid and embedded in epoxy resin. Routine thick
sections were cut to select representative area for ultra-thin
sectioning. Ultra-thin sections were double stained with
uranyl acetate and lead citrate and examined under a
transmission electron microscope (TEM, Morgagni 268,
Holland). Microscopic examination showed a cellular
tumor arranged in solid sheets, nests and trabecular pat-
tern with few residual normal thyroid follicles (Fig 1b–f).
Tumor cells were polygonal, round to oval, at places
showing spindling. Cellular outlines were indistinct with
moderate to abundant amphophilic cytoplasm. Nuclei
were vesicular and showed moderate pleomorphism,
multi-nucleation and conspicuous nucleoli. Frequent
mitoses were present but necrosis was not seen. Scant
perivascular eosinophilic amorphous material was
present which was reactive to Congo red stain and showed
apple green birefringence on polarization. Brown-black,
coarse intracytoplasmic pigment was present in the tumor
cells (Fig. 1e–f) which bleached with Masson-Fontana
stain and it was negative for iron stain. Melanin was
present in all types of tumor cells. Tumor cells showed dif-
fuse immunopositivity for calcitonin, HMB-45, carci-
noembryonic antigen, synaptophysin, chromogranin,
vimentin and epithelial membrane antigen but focal para-
nuclear dot-like positivity for cytokeratin (Fig 2a–f), and
were negative for thyroglobulin, S-100, melan-A and TTF
(Table 2). Electron microscopy revealed abundant com-
pound melanosomes, premelanosomes in various stages
of melanogenesis and sparse membrane bound dense
core neurosecretory granules measuring 50–200 nm along
with intermediate filaments (Fig 3). Patient was dis-
charged on fourth post operative day and was doing well.
Follow up: However in the follow up, she developed local
recurrence twice after 10 months and 18 months of oper-
ation in the soft tissue of neck. Serum calcitonin levels
were within normal range. Excision of recurrent nodules
showed medullary carcinoma without pigment produc-
tion. After 3 months of second recurrence, she developed
multiple nodules at the same site and surgical excision
was done in another hospital. After this surgery she had
multiple metastases to the scalp and died after 24 months
of first surgery. Mutational analysis for ret oncogene could
not be done.
Discussion
Medullary carcinoma of thyroid (MTC) is a tumor of thy-
roid parafollicular C cells, which are derived from neural
crest. MTC can mimic any tumor structurally and func-
tionally and has also been described as solid carcinoma,
hyaline carcinoma and C-cell carcinoma [1]. Classically
tumor cells are round to polygonal with amphophilic
granular cytoplasm and have medium sized nucleus.
Tumor cells are spread in solid sheets separated by highly
vascular stroma, hyalinised collagen and amyloid [11].
Unusual varieties of MTC described are melanin produc-
ing MTC [3-11], true papillary form [12], mucinous or
amphicrine form [13], clear cell variant [14], small cell
variant [15] and giant cell type [16].
Our patient was a 52-year-old lady with mass in the thy-
roid region in the neck for three months. Histopathologic
examination showed features of medullary carcinoma
with melanin production. Mitoses were frequent (>10/
hpf) in some foci which is unusual for MTC. Multinucle-
ated tumor giant cells were present. These giant cells had
Table 2: Summary and comparison of immunohisochemical profile of the previously reported cases
IHC Present case *3 *4 *5 *6 *7 *8 *9 *10 *11
Calcitonin + ++++++++ +
H M B - 4 5 / M e l a n i n  s t a i n + ++++++- + +
Carcinoembryonic antigen + + +
Synaptophysin +
Chromogranin + + + + +
Epithelial membrane antigen +
Vimentin +
Cytokeratin + + +
S-100 - - + + +
Melan-A -
*REFERENCE NUMBER
+ – positive,
- – negativeDiagnostic Pathology 2008, 3:2 http://www.diagnosticpathology.org/content/3/1/2
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hyper chromatic, pleomorphic nuclei with prominent
amphophilic to eosinophilic nucleoli. Positivity for Fon-
tana-Masson and negativity for iron stain confirmed pig-
ment to be melanin. Tumor cells were positive for
calcitonin which is the most specific marker for parafollic-
ular cells [1] and proved beyond doubt that this was a
melanin producing MTC and not a metastatic melanoma.
Positive immunostaining for cytokeratin, chromogranin
A, synaptophysin and carcinoembyonic antigen further
buttressed above diagnosis. MTCs are generally negative
for thyroglobulin as has been seen in the present case
[17]. However mixed medullary carcinomas are known
for thyroglobulin immunopositivity secondary to follicu-
lar differentiation. It has been hypothesized that mixed
medullary carcinoma of the thyroid may be derived from
common stem cells capable of differentiating into both
follicular and parafollicular tumor cells [18]. Conversely,
Volante et al [19] raised the possibility that trophic factors
secreted by neoplastic and host cells might have a signifi-
cant role in the tumorigenesis of mixed MTC. The demon-
stration of immunoreactive calcitonin within the
neoplastic cells and the lack of thyroglobulin reactivity
further support the diagnosis of a pure medullary carci-
noma. Ultra structurally, tumor cells contained abundant
melanosomes and premelanosomes but sparse neurose-
cretory dense core granules.
Black thyroid glands have been described in patients of
cystic fibrosis, obstructive lung diseases and in patients
who received minocycline for long duration. Pigmenta-
tion in these conditions is secondary to accumulation of
lipofuscin. Presence of melanin in this case along with
absence of clinical features ruled out these conditions.
Metastatic melanoma has to be excluded before consider-
ing melanin producing medullary carcinoma as the pri-
mary diagnosis. Melanoma is the most common
metastatic tumor in the thyroid [20,21]. Routine hema-
toxylin and eosin stain may not help much in differentiat-
ing melanoma from MTC with melanin production. In
the present case the tumor cells showed pleomorphism
with prominent nucleoli, foci of high mitotic counts and
the melanin pigment. Features favoring MTC were orga-
noid pattern; moderate to abundant eosinophilic cyto-
Electronmicrographs showing oval to spindle shaped cells  with prominent nucleoli (a, ×2250 original magnification)  packed with compound melanosomes and premelanosomes  (b, ×6250); higher magnification of premelanosomes demon- strating internal structure (c, ×8250) and electron dense neu- rosecretory granules (d, ×6250) Figure 3
Electronmicrographs showing oval to spindle shaped cells 
with prominent nucleoli (a, ×2250 original magnification) 
packed with compound melanosomes and premelanosomes 
(b, ×6250); higher magnification of premelanosomes demon-
strating internal structure (c, ×8250) and electron dense neu-
rosecretory granules (d, ×6250).
Photomicrographs showing tumor cells to be immunoposi- tive for chromogranin A, synaptophysin, CEA, Calcitonin,  HMB-45, and pan-CK (a-f, ×200 each) Figure 2
Photomicrographs showing tumor cells to be immunoposi-
tive for chromogranin A, synaptophysin, CEA, Calcitonin, 
HMB-45, and pan-CK (a-f, ×200 each).Diagnostic Pathology 2008, 3:2 http://www.diagnosticpathology.org/content/3/1/2
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plasm and scant amyloid like material, however
melanoma can show these features [21]. The presence of
amyloid material favors the possibility of former. Immu-
nohistochemistry and ultra structural examination are
essential tools in diagnosing MTC [11] and differentiating
it from melanoma in difficult situations. Calcitonin is
indispensable in these situations. Immunohistochemical
expression of S-100 protein and especially HMB-45 by the
pigmented tumor cells is further proof of melanocytic dif-
ferentiation. All the previously reported cases showed cal-
citonin and HMB-45 expression in tumor cells. Ikeda et al
did not find HMB-45 positivity in the sustentacular-like
pigmented cells, possibly due to loss of antigenicity sec-
ondary to prebleaching. These cells were however, posi-
tive for S-100 stain. Marcus et al demonstrated presence of
melanin and neurosecretory granules by Fontana-Masson
and Gremalius argyrophil silver stain. Most of the cases
showed chromogranin positivity to support for neuroen-
docrine differentiation. Electron microscopy showing the
premelanosomes and neurosecretory granules within the
same tumor cells clinches the diagnosis of MTC with mel-
anin production [3,4]. Melanoma does not contain neu-
rosecretory granules and intermediate filaments of the
cytokeratin type [22].
Melanin producing medullary carcinoma thyroid was first
described by Marcus et al in 1982 [3] and since then eight
cases have been reported in the literature [3-11] including
one case from our institute [10]. Salient features are sum-
marized in Table 1. Age ranged from 20 to 72 years with
equal male to female ratio. Duration of symptoms varied
from 15 days to 14 years. None of them showed c-cell
hyperplasia. Interestingly all the reported cases showed
variable histomorphological features. In the case reported
by Marcus et al there was evidence of only scanty melanin
production which was localized to dendritic cells which
did not have neurosecretory granules [3] Similarly the
case reported by Ikeda et al [9] showed paraganglioma
like picture and pigment was localized to the sustentacu-
lar cells. The possibility of paraganglioma was not consid-
ered in view of calcitonin expression in these cells. In later
studies it has been shown that melanosomes and neuro-
secretory granules are present in the same tumor cells [5].
The case reported by Kimura et al [6] showed glandular
differentiation and both types of cells were pigmented.
We tend to agree that tumor arises by polyclonal evolu-
tion of a common neoplastic precursor cell, able to pro-
duce both melanin and calcitonin. These cells are derived
from neural crest which has melanocytic and c-cell charac-
teristics within the same cells or show a mixed phenotypic
expression. This is further supported that some of pig-
mented medullary carcinomas showed paraganglioma
like morphology [9] which were derivatives of neural
crest.
The prognosis of this variant is not exactly known, due to
scarcity of cases. Of the nine previously published cases,
follow up was mentioned in five patients only. Of these,
two patients showed systemic metastases in the follow up
and one had lymph node metastasis at the time of presen-
tation. The case under discussion had very high mitotic
count in some foci and had recurrence thrice in the soft
tissue of neck and metastases to skull bones within 24
months of surgery. The high mitotic rate as seen in this
case may be associated with poor prognosis. Whether the
presence of melanin contribute to its aggressiveness
remains to be elucidated. Therefore more cases of such
type need to be documented in order to predict the exact
behavior of this variant.
Conclusion
Melanocytic differentiation in medullary carcinoma of
thyroid is very rare. The prognostic and therapeutic signif-
icance of this variant of MTC is not exactly known but this
variant appears to be more aggressive; hence it needs to be
documented in literature to know the exact behavior of
this variant.
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